4 New HIV specific latency reversing agents with novel targets that synergise with HIV Tat and the bromodomain inhibitor, JQ1 to reactivate HIV from primary cells.
J. Jacobson,
B. Sleebs,
K. Jarman,
W. Nguyen,
T. Mota,
L. Harty,
G. Khoury,
N. Tay,
P. Cameron,
S. Lewin,
D.F.J. Purcell
Affiliations
J. Jacobson
Doherty Institue for Infection and Immunity, University of Melbourne, Melbourne, Australia
B. Sleebs
Walter and Elisa Hall Institute, Parkville, Australia
K. Jarman
Walter and Elisa Hall Institute, Parkville, Australia
W. Nguyen
Walter and Elisa Hall Institute, Parkville, Australia
T. Mota
Doherty Institue for Infection and Immunity, University of Melbourne, Melbourne, Australia
L. Harty
Doherty Institue for Infection and Immunity, University of Melbourne, Melbourne, Australia
G. Khoury
Doherty Institue for Infection and Immunity, University of Melbourne, Melbourne, Australia
N. Tay
Doherty Institue for Infection and Immunity, University of Melbourne, Melbourne, Australia
P. Cameron
Doherty Institue for Infection and Immunity, University of Melbourne, Melbourne, Australia
S. Lewin
Doherty Institue for Infection and Immunity, University of Melbourne, Melbourne, Australia
D.F.J. Purcell
Doherty Institue for Infection and Immunity, University of Melbourne, Melbourne, Australia
